Vicken Karageozian
Founder at Allegro Ophthalmics LLC
Vicken Karageozian active positions
Companies | Position | Start | End |
---|---|---|---|
University of California, Irvine | Corporate Officer/Principal | - | - |
Allegro Ophthalmics LLC
Allegro Ophthalmics LLC BiotechnologyHealth Technology Allegro Ophthalmics LLC operates as a biopharmaceutical company. It focuses on the development of novel integrin-regulating therapies for the treatment of ocular diseases. The company was founded by Hampar Karageozian and John Park and is headquartered in San Juan Capistrano, CA. | Director/Board Member | - | - |
Chief Executive Officer | 2018-07-31 | - | |
Founder | 1992-12-31 | - | |
President | 2016-03-14 | - | |
Chief Tech/Sci/R&D Officer | - | - |
Career history of Vicken Karageozian
Former positions of Vicken Karageozian
Companies | Position | Start | End |
---|---|---|---|
Allergan Pharmaceuticals Ltd., Inc.
Allergan Pharmaceuticals Ltd., Inc. Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA | Corporate Officer/Principal | - | - |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Corporate Officer/Principal | - | - |
VitreoRetinal Technologies, Inc.
VitreoRetinal Technologies, Inc. Medical SpecialtiesHealth Technology Vitreoretinal Technologies, Inc. was a pharmaceutical company. It was used to develop and commercialize innovative therapeutic systems for the treatment of serious ocular diseases. The company was founded in July 1999 and was headquartered in Irvine, CA. | Chairman | 1999-06-30 | 2009-08-06 |
Chief Tech/Sci/R&D Officer | 1999-06-30 | - | |
Founder | 2009-07-19 | - | |
Sales & Marketing | 2009-08-09 | - |
Training of Vicken Karageozian
Tufts University | Doctorate Degree |
University of California San Diego | Undergraduate Degree |
Statistics
International
United States | 8 |
Operational
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
VitreoRetinal Technologies, Inc.
VitreoRetinal Technologies, Inc. Medical SpecialtiesHealth Technology Vitreoretinal Technologies, Inc. was a pharmaceutical company. It was used to develop and commercialize innovative therapeutic systems for the treatment of serious ocular diseases. The company was founded in July 1999 and was headquartered in Irvine, CA. | Health Technology |
Allergan Pharmaceuticals Ltd., Inc.
Allergan Pharmaceuticals Ltd., Inc. Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA | Health Technology |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
Allegro Ophthalmics LLC
Allegro Ophthalmics LLC BiotechnologyHealth Technology Allegro Ophthalmics LLC operates as a biopharmaceutical company. It focuses on the development of novel integrin-regulating therapies for the treatment of ocular diseases. The company was founded by Hampar Karageozian and John Park and is headquartered in San Juan Capistrano, CA. | Health Technology |
- Stock Market
- Insiders
- Vicken Karageozian
- Experience